Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001439222-22-000002
Filing Date
2022-01-10
Accepted
2022-01-10 16:07:18
Documents
2
Period of Report
2022-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_164184881024239.html 3  
1 FORM 3 wf-form3_164184881024239.xml 3 15738
2 POA J BURNS ex-24.htm EX-24 4256
  Complete submission text file 0001439222-22-000002.txt   21446
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AGIOS PHARMACEUTICALS 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Burns James William (Reporting) CIK: 0001900772 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36014 | Film No.: 22521335